bullish
Classys (214150 KS): Will Continue To Remain On a Consistent Growth Path Through New Launches
394 Views11 Jan 2023 19:35
SUMMARY
- Classys (214150 KS) has started selling Volnewmer from the end of October 2022. With a safe and comfortable treatment experience, Volnewmer will become another strong growth engine.
- The ratio of consumables sales to total sales is gradually increasing from 33% in Q1 2022 and 37% in Q2 2022 to 46% in Q3 2022, leading to improved profitability.
- Classys recorded 30%+ revenue growth and margin improvement in Q3, with the cumulative sales in Q3 of this year exceeded 2021 annual sales, which was already the largest.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Rising
Tina Banerjee
Global Healthcare Analyst
Price Chart(Sign Up to Access)
- Jeisys Medical (287410 KS): Solid Q1 Result; New Product Launch and China Expansion to Drive Growth29 May 2023
- InMode Ltd (INMD US): Decelerating Growth & Unfavorable Macro Environment Are Major Concerns26 Feb 2023
- Classys (214150 KS): Record-High Sales and Profit in 2022; Geography Expansion to Accelerate Growth17 Feb 2023
- Classys (214150 KS): Overseas Expansion +Portfolio Enlargement = Consistent & Sustainable Growth25 Sep 2022
- Classys (214150 KS): Bain Capital Deal Implies 11% Upside Potential30 Jan 2022
x